Annual EBITDA:
-$35.57M+$113.56M(+76.15%)Summary
- As of today (October 8, 2025), AVDL annual EBITDA is -$35.57 million, with the most recent change of +$113.56 million (+76.15%) on December 31, 2024.
- During the last 3 years, AVDL annual EBITDA has risen by +$46.82 million (+56.83%).
- AVDL annual EBITDA is now -136.07% below its all-time high of $98.59 million, reached on December 31, 2017.
Performance
AVDL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$9.92M+$11.70M(+657.50%)Summary
- As of today (October 8, 2025), AVDL quarterly EBITDA is $9.92 million, with the most recent change of +$11.70 million (+657.50%) on June 1, 2025.
- Over the past year, AVDL quarterly EBITDA has increased by +$21.10 million (+188.73%).
- AVDL quarterly EBITDA is now -75.16% below its all-time high of $39.92 million, reached on June 30, 2020.
Performance
AVDL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$7.86M+$21.10M(+159.43%)Summary
- As of today (October 8, 2025), AVDL TTM EBITDA is $7.86 million, with the most recent change of +$21.10 million (+159.43%) on June 1, 2025.
- Over the past year, AVDL TTM EBITDA has increased by +$103.30 million (+108.24%).
- AVDL TTM EBITDA is now -93.61% below its all-time high of $123.11 million, reached on September 30, 2017.
Performance
AVDL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AVDL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +76.2% | +188.7% | +108.2% |
| 3Y3 Years | +56.8% | +133.6% | +107.5% |
| 5Y5 Years | -50.6% | -75.2% | -36.0% |
AVDL EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +76.2% | at high | +116.1% | at high | +105.3% |
| 5Y | 5-Year | -470.4% | +76.2% | at high | +116.1% | -36.0% | +105.3% |
| All-Time | All-Time | -136.1% | +76.2% | -75.2% | +113.5% | -93.6% | +105.3% |
AVDL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $9.92M(+657.5%) | $7.86M(+159.4%) |
| Mar 2025 | - | -$1.78M(-11.7%) | -$13.23M(+62.8%) |
| Dec 2024 | -$35.57M(+76.1%) | -$1.59M(-220.9%) | -$35.57M(+41.2%) |
| Sep 2024 | - | $1.32M(+111.8%) | -$60.51M(+36.6%) |
| Jun 2024 | - | -$11.18M(+53.6%) | -$95.44M(+34.5%) |
| Mar 2024 | - | -$24.12M(+9.1%) | -$145.71M(+2.3%) |
| Dec 2023 | -$149.13M(-52.8%) | -$26.53M(+21.1%) | -$149.11M(-2.1%) |
| Sep 2023 | - | -$33.61M(+45.3%) | -$146.10M(-13.6%) |
| Jun 2023 | - | -$61.45M(-123.3%) | -$128.60M(-33.1%) |
| Mar 2023 | - | -$27.52M(-17.0%) | -$96.65M(+1.0%) |
| Dec 2022 | -$97.60M(-18.5%) | -$23.52M(-46.0%) | -$97.60M(-1.3%) |
| Sep 2022 | - | -$16.11M(+45.4%) | -$96.37M(+8.4%) |
| Jun 2022 | - | -$29.50M(-3.6%) | -$105.23M(-8.5%) |
| Mar 2022 | - | -$28.47M(-27.7%) | -$96.95M(-17.7%) |
| Dec 2021 | -$82.39M(-958.0%) | -$22.29M(+10.8%) | -$82.39M(-16.8%) |
| Sep 2021 | - | -$24.98M(-17.7%) | -$70.53M(-20.1%) |
| Jun 2021 | - | -$21.22M(-52.6%) | -$58.71M(-2520.2%) |
| Mar 2021 | - | -$13.90M(-33.3%) | $2.43M(-74.7%) |
| Dec 2020 | $9.60M(+140.7%) | -$10.43M(+20.8%) | $9.60M(-21.8%) |
| Sep 2020 | - | -$13.16M(-133.0%) | $12.28M(-45.6%) |
| Jun 2020 | - | $39.92M(+693.3%) | $22.56M(+210.7%) |
| Mar 2020 | - | -$6.73M(+13.2%) | -$20.38M(+13.7%) |
| Dec 2019 | -$23.61M(+75.2%) | -$7.75M(-169.2%) | -$23.61M(+73.6%) |
| Sep 2019 | - | -$2.88M(+4.8%) | -$89.41M(+8.9%) |
| Jun 2019 | - | -$3.02M(+69.7%) | -$98.17M(-4.3%) |
| Mar 2019 | - | -$9.96M(+86.5%) | -$94.13M(+1.1%) |
| Dec 2018 | -$95.14M(-196.5%) | -$73.54M(-531.4%) | -$95.14M(-283.5%) |
| Sep 2018 | - | -$11.65M(-1236.3%) | -$24.81M(-257.4%) |
| Jun 2018 | - | $1.02M(+109.3%) | $15.76M(-69.7%) |
| Mar 2018 | - | -$10.98M(-242.7%) | $52.06M(-47.2%) |
| Dec 2017 | $98.59M(+1619.5%) | -$3.20M(-111.1%) | $98.59M(-19.9%) |
| Sep 2017 | - | $28.92M(-22.5%) | $123.11M(+50.5%) |
| Jun 2017 | - | $37.33M(+5.0%) | $81.79M(+126.3%) |
| Mar 2017 | - | $35.55M(+66.8%) | $36.14M(+526.3%) |
| Dec 2016 | $5.73M(-93.7%) | $21.31M(+271.8%) | $5.77M(+159.5%) |
| Sep 2016 | - | -$12.40M(-49.1%) | -$9.70M(-126.7%) |
| Jun 2016 | - | -$8.32M(-260.5%) | $36.27M(-8.2%) |
| Mar 2016 | - | $5.18M(-11.3%) | $39.51M(-34.1%) |
| Dec 2015 | $90.84M(+229.3%) | $5.84M(-82.6%) | $59.97M(+135.1%) |
| Sep 2015 | - | $33.56M(+760.7%) | $25.50M(+292.8%) |
| Jun 2015 | - | -$5.08M(-119.8%) | -$13.23M(+43.7%) |
| Mar 2015 | - | $25.64M(+189.6%) | -$23.49M(+66.2%) |
| Dec 2014 | -$70.24M(-40.2%) | -$28.62M(-454.0%) | -$69.51M(-62.9%) |
| Sep 2014 | - | -$5.17M(+66.3%) | -$42.67M(+2.2%) |
| Jun 2014 | - | -$15.34M(+24.8%) | -$43.64M(+29.0%) |
| Mar 2014 | - | -$20.39M(-1047.2%) | -$61.44M(-22.6%) |
| Dec 2013 | -$50.10M(-712.2%) | -$1.78M(+71.0%) | -$50.10M(-12.6%) |
| Sep 2013 | - | -$6.14M(+81.5%) | -$44.50M(-1.1%) |
| Jun 2013 | - | -$33.15M(-266.6%) | -$44.02M(-175.7%) |
| Mar 2013 | - | -$9.04M(-336.6%) | -$15.97M(-40.7%) |
| Dec 2012 | -$6.17M(-19.5%) | $3.82M(+167.5%) | -$11.35M(+27.6%) |
| Sep 2012 | - | -$5.66M(-11.2%) | -$15.68M(-94.5%) |
| Jun 2012 | - | -$5.09M(-15.2%) | -$8.06M(-41.0%) |
| Mar 2012 | - | -$4.42M(-759.5%) | -$5.72M(-10.7%) |
| Dec 2011 | -$5.16M(-27.6%) | -$514.00K(-126.3%) | -$5.16M(-1441.2%) |
| Sep 2011 | - | $1.96M(+171.3%) | -$335.00K(+92.2%) |
| Jun 2011 | - | -$2.74M(+29.0%) | -$4.28M(+16.6%) |
| Mar 2011 | - | -$3.86M(-189.5%) | -$5.13M(-26.7%) |
| Dec 2010 | -$4.05M | $4.31M(+317.3%) | -$4.05M(+66.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$1.99M(+44.7%) | -$12.05M(+1.9%) |
| Jun 2010 | - | -$3.59M(-29.1%) | -$12.28M(-13.5%) |
| Mar 2010 | - | -$2.78M(+24.5%) | -$10.82M(-99.6%) |
| Dec 2009 | -$5.42M(-25.6%) | -$3.69M(-65.9%) | -$5.42M(-248.3%) |
| Sep 2009 | - | -$2.22M(-4.3%) | $3.66M(+21.6%) |
| Jun 2009 | - | -$2.13M(-181.4%) | $3.01M(+94.5%) |
| Mar 2009 | - | $2.62M(-51.5%) | $1.55M(+135.8%) |
| Dec 2008 | -$4.32M(+87.5%) | $5.39M(+287.8%) | -$4.32M(+73.2%) |
| Sep 2008 | - | -$2.87M(+20.0%) | -$16.10M(+23.2%) |
| Jun 2008 | - | -$3.59M(-10.6%) | -$20.97M(+29.8%) |
| Mar 2008 | - | -$3.25M(+49.2%) | -$29.86M(+13.8%) |
| Dec 2007 | -$34.65M(-4.4%) | -$6.39M(+17.4%) | -$34.65M(+0.4%) |
| Sep 2007 | - | -$7.74M(+38.0%) | -$34.80M(+4.4%) |
| Jun 2007 | - | -$12.48M(-55.2%) | -$36.42M(-12.5%) |
| Mar 2007 | - | -$8.04M(-22.8%) | -$32.38M(+2.5%) |
| Dec 2006 | -$33.20M(+7.8%) | -$6.55M(+30.0%) | -$33.20M(+9.1%) |
| Sep 2006 | - | -$9.36M(-10.9%) | -$36.54M(+4.1%) |
| Jun 2006 | - | -$8.43M(+4.9%) | -$38.10M(+0.2%) |
| Mar 2006 | - | -$8.86M(+10.3%) | -$38.18M(-6.0%) |
| Dec 2005 | -$36.03M(-417.0%) | -$9.88M(+9.5%) | -$36.02M(-77.8%) |
| Sep 2005 | - | -$10.92M(-28.3%) | -$20.26M(-210.7%) |
| Jun 2005 | - | -$8.51M(-26.9%) | -$6.52M(-2505.9%) |
| Mar 2005 | - | -$6.71M(-214.0%) | $271.00K(-97.6%) |
| Dec 2004 | $11.37M(+480.5%) | $5.88M(+108.8%) | $11.37M(+87.8%) |
| Sep 2004 | - | $2.82M(+263.8%) | $6.05M(+305.3%) |
| Jun 2004 | - | -$1.72M(-139.2%) | $1.49M(-7.7%) |
| Mar 2004 | - | $4.39M(+672.2%) | $1.62M(+134.2%) |
| Dec 2003 | -$2.99M(-341.5%) | $568.00K(+132.6%) | -$4.73M(+42.9%) |
| Sep 2003 | - | -$1.74M(-9.1%) | -$8.28M(-91.9%) |
| Jun 2003 | - | -$1.60M(+18.5%) | -$4.31M(-288.9%) |
| Mar 2003 | - | -$1.96M(+34.3%) | $2.28M(-74.1%) |
| Dec 2002 | $1.24M(+165.6%) | -$2.98M(-234.1%) | $8.80M(+8529.4%) |
| Sep 2002 | - | $2.22M(-55.5%) | $102.00K(-79.8%) |
| Jun 2002 | - | $5.00M(+9.6%) | $504.00K(+124.4%) |
| Mar 2002 | - | $4.56M(+139.0%) | -$2.06M(+34.6%) |
| Dec 2001 | -$1.89M(+87.4%) | -$11.68M(-545.0%) | -$3.15M(+79.8%) |
| Sep 2001 | - | $2.63M(+7.9%) | -$15.58M(-2.5%) |
| Jun 2001 | - | $2.43M(-29.8%) | -$15.21M(-2.8%) |
| Mar 2001 | - | $3.47M(+114.4%) | -$14.80M(+9.1%) |
| Dec 2000 | -$14.99M(-158.8%) | -$24.11M(-903.6%) | -$16.28M(-407.6%) |
| Sep 2000 | - | $3.00M(+5.6%) | -$3.21M(+29.0%) |
| Jun 2000 | - | $2.84M(+43.4%) | -$4.52M(+28.4%) |
| Mar 2000 | - | $1.98M(+118.0%) | -$6.32M(+9.7%) |
| Dec 1999 | -$5.79M(+29.8%) | -$11.03M(-753.6%) | -$7.00M(+41.0%) |
| Sep 1999 | - | $1.69M(+61.4%) | -$11.86M(-0.1%) |
| Jun 1999 | - | $1.05M(-19.5%) | -$11.85M(-16.2%) |
| Mar 1999 | - | $1.30M(+108.2%) | -$10.19M(+27.7%) |
| Dec 1998 | -$8.25M(+0.6%) | -$15.89M(-1034.8%) | -$14.09M(-18.4%) |
| Sep 1998 | - | $1.70M(-37.0%) | -$11.90M(+4.0%) |
| Jun 1998 | - | $2.70M(+203.8%) | -$12.40M(+10.1%) |
| Mar 1998 | - | -$2.60M(+81.0%) | -$13.80M(-51.6%) |
| Dec 1997 | -$8.30M(-2.5%) | -$13.70M(-1241.7%) | -$9.10M(-12.3%) |
| Sep 1997 | - | $1.20M(-7.7%) | -$8.10M(+5.8%) |
| Jun 1997 | - | $1.30M(-38.1%) | -$8.60M(+4.4%) |
| Mar 1997 | - | $2.10M(+116.5%) | -$9.00M(+25.0%) |
| Dec 1996 | -$8.10M | -$12.70M(-1914.3%) | -$12.00M(-1814.3%) |
| Sep 1996 | - | $700.00K(-22.2%) | $700.00K(>+9900.0%) |
| Jun 1996 | - | $900.00K(+200.0%) | $0.00(+100.0%) |
| Mar 1996 | - | -$900.00K | -$900.00K |
FAQ
- What is Avadel Pharmaceuticals plc annual EBITDA?
- What is the all-time high annual EBITDA for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual EBITDA year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly EBITDA year-on-year change?
- What is Avadel Pharmaceuticals plc TTM EBITDA?
- What is the all-time high TTM EBITDA for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc TTM EBITDA year-on-year change?
What is Avadel Pharmaceuticals plc annual EBITDA?
The current annual EBITDA of AVDL is -$35.57M
What is the all-time high annual EBITDA for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual EBITDA is $98.59M
What is Avadel Pharmaceuticals plc annual EBITDA year-on-year change?
Over the past year, AVDL annual EBITDA has changed by +$113.56M (+76.15%)
What is Avadel Pharmaceuticals plc quarterly EBITDA?
The current quarterly EBITDA of AVDL is $9.92M
What is the all-time high quarterly EBITDA for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly EBITDA is $39.92M
What is Avadel Pharmaceuticals plc quarterly EBITDA year-on-year change?
Over the past year, AVDL quarterly EBITDA has changed by +$21.10M (+188.73%)
What is Avadel Pharmaceuticals plc TTM EBITDA?
The current TTM EBITDA of AVDL is $7.86M
What is the all-time high TTM EBITDA for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high TTM EBITDA is $123.11M
What is Avadel Pharmaceuticals plc TTM EBITDA year-on-year change?
Over the past year, AVDL TTM EBITDA has changed by +$103.30M (+108.24%)